Cansartan-Mepha plus 8/12.5

Cansartan-Mepha plus 8/12.5 is a medicine authorised by Swissmedic under authorisation number 61215. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 January 2011 and the authorisation is valid without a time limit. ATC code C09DA06 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 61215
  • ATC C09DA06
  • Synthetic medicines
Authorisation data
Authorisation number61215
NameCansartan-Mepha plus 8/12.5
Full nameCansartan-Mepha plus 8/12.5, Tabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DA06
First authorisation24 January 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Cansartan-Mepha plus 8/12.5, TablettenB24 January 2011
2Cansartan-Mepha plus 16/12.5, TablettenB24 January 2011
3Cansartan-Mepha plus 32/12.5, TablettenB05 September 2014
4Cansartan-Mepha plus 32/25, TablettenB05 September 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
528Tablette(n)C09DA0602.07.2.B
698Tablette(n)C09DA0602.07.2.B
728Tablette(n)C09DA0602.07.2.B
898Tablette(n)C09DA0602.07.2.B
928Tablette(n)C09DA0602.07.2.B
1098Tablette(n)C09DA0602.07.2.B
1128Tablette(n)C09DA0602.07.2.B
1298Tablette(n)C09DA0602.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Cansartan-Mepha plus 8/12.5 authorised in Switzerland?

Yes. Cansartan-Mepha plus 8/12.5 is authorised by Swissmedic under authorisation number 61215, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Cansartan-Mepha plus 8/12.5 have?

Cansartan-Mepha plus 8/12.5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Cansartan-Mepha plus 8/12.5?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com